Effect of Dapagliflozin as an Add-on Therapy to Insulin on the Glycemic Variability in Subjects with Type 2 Diabetes Mellitus (DIVE): A Multicenter, Placebo-Controlled, Double-Blind, Randomized Study

BACKGROUND: Glycemic variability is associated with the development of diabetic complications and hypoglycemia. However, the effect of sodium-glucose transporter 2 (SGLT2) inhibitors on glycemic variability is controversial. We aimed to examine the effect of dapagliflozin as an add-on therapy to ins...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seung-Hwan, Min, Kyung-Wan, Lee, Byung-Wan, Jeong, In-Kyung, Yoo, Soon-Jib, Kwon, Hyuk-Sang, Choi, Yoon-Hee, Yoon, Kun-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164951/
https://www.ncbi.nlm.nih.gov/pubmed/32602273
http://dx.doi.org/10.4093/dmj.2019.0203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164951/
https://www.ncbi.nlm.nih.gov/pubmed/32602273
http://dx.doi.org/10.4093/dmj.2019.0203

Ejemplares similares